McBride logo McBride (LON:MCB) management said the group delivered a third consecutive year of “strong financial and operational performance” in the six months ended Dec. 31, 2025, while reaching a key milestone in its multi-year transformation program with the first SAP S/4HANA go-live in the U.K. Chief Executive Officer Chris Smith said the period could be summarized by three themes: continued performance, the SAP implementation milestone, and a “balanced approach to capital allocation” combining share ...

Invitation Homes Inc. (NYSE:INVH) is among the 20 Best Investments in 2026. Invitation Homes Inc. (INVH) PT Lowered From $33 on Softer Pricing Outlook The next stock on our list is Invitation Homes Inc. (NYSE:INVH). TheFly reported on February 20 that Evercore ISI lowered its price target for INVH from $33 to $31 and gave it an Outperform rating. A softer pricing environment that affected the company's short-term perspective also caused the firm to lower its revenue growth target. Invitation Homes Inc ...

Broyhill Asset Management, an investment advisor, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. 2025 witnessed extreme market concentration and a strong focus on artificial intelligence, leaving many sectors behind. The Portfolio, which has been significantly reshaped, now trades at a substantial discount relative to the broader market. The firm strongly believes it will benefit as market fundamentals improve. For the year, the portfolio declined by 1.4%, un ...

Core Insights - Jack Henry & Associates, Inc. (NASDAQ: JKHY) is recognized as one of the best investments for 2026 and has been added to Wells Fargo's "Fab 5" list of top fintech picks [1][3][9] Company Performance and Outlook - Wells Fargo upgraded JKHY from Equal Weight to Overweight, raising its price target from $181 to $196, reflecting increased confidence in the company's revenue growth for 2027 [3][4] - The firm highlighted JKHY's strong competitive position and attractive valuation, with potential upside compared to 2027 and 2028 estimates [3][4] Recent Developments - On February 11, 2023, Jack Henry announced that Blue Sky Bank selected its technology to modernize retail and commercial banking services, utilizing Jack Henry's core platform and integrated digital solutions [5] - Blue Sky Bank has grown its assets from just over $200 million in 2018 to $1.3 billion today, indicating a significant expansion across 15 branches in Oklahoma and Texas [5] Industry Context - Jack Henry provides technology solutions and payment processing services for banks and credit unions, facilitating secure and efficient financial operations and digital banking experiences [6]

A $20 aspirin doesn't happen by accident. It happens by design. Mark Cuban, billionaire entrepreneur and co-founder of Cost Plus Drugs, is not new to healthcare disruption. His pharmaceutical company was built on a simple premise: show the cost, add a transparent markup, and publish it. So when he returned to his blog "Blog Maverick" last year with a post titled "A Few Words On Healthcare," he wasn't just offering commentary. He was expanding that same pricing philosophy to the entire $5 trillion U.S. heal ...

Microsoft Corporation (MSFT) stands among this year’s more sobering mega-cap stories. The stock has declined roughly 17.16% since the start of the year, a clear reminder that even artificial intelligence (AI) cannot suspend valuation gravity. Still, the tape showed a flicker of resilience. Shares gained 1.2% on Tuesday, Feb. 24, after Microsoft unveiled a partnership with SpaceX’s Starlink to expand global internet access. The move signals pragmatic leadership. Despite Elon Musk’s public dispute with Open ...

Core Insights - Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is recognized as one of the best investment stocks for 2026, indicating strong future potential in the market [1][2]. Company Developments - Truist Securities downgraded HRMY from Buy to Hold due to concerns raised during a patent trial against AET Pharma, suggesting a potential negative outcome for Harmony's case and highlighting risks for the Wakix franchise, with generic competition expected before 2029 [3][8]. - On February 17, the U.S. FDA approved Harmony's supplemental New Drug Application for WAKIX (pitolisant) tablets, allowing treatment for cataplexy in children aged six and older, marking it as the first FDA-approved non-scheduled therapy for narcolepsy [4][5]. Industry Context - Harmony Biosciences focuses on developing therapies for rare neurological disorders, particularly innovative treatments for narcolepsy and other sleep-related diseases, positioning itself within a niche but critical segment of the biopharmaceutical industry [5].

Core Viewpoint - Broyhill Asset Management's fourth-quarter 2025 investor letter emphasizes the significant market concentration on artificial intelligence, leading to underperformance in many sectors, while the portfolio trades at a substantial discount compared to the broader market [1]. Company Summary - Dollar Tree, Inc. (NASDAQ:DLTR) operates a chain of discount stores and has a market capitalization of $26.047 billion [2]. - As of February 25, 2026, Dollar Tree's stock closed at $127.70 per share, with a one-month return of 8.86% and a 52-week gain of 74.55% [2]. - The company was highlighted as a major contributor to Broyhill's portfolio performance, with the stock recovering due to mispriced market perceptions and improvements in business execution [3]. Investment Insights - Broyhill Asset Management noted that Dollar Tree's turnaround has been uneven, but the simplification of its business model and execution improvements have led to a belief that its normalized earnings power is significantly higher than market expectations [3]. - Despite recognizing Dollar Tree's potential, Broyhill suggests that certain AI stocks may offer greater upside potential and less downside risk compared to Dollar Tree [4].

Independence Realty Trust, Inc. (NYSE:IRT) is among the 20 Best Investments in 2026. Independence Realty Trust, Inc. (IRT) Swings to Q4 Profit With $33.3M in Net Income Independence Realty Trust, Inc. (NYSE:IRT) is among the best investments. TheFly reported on February 18 that Citi reduced its price target for IRT to $18 from $19.50 and maintained a Neutral rating on the stock. The fourth quarter and year-end results of Independence Realty Trust, Inc. (NYSE:IRT), which concluded on December 31, 2025, ...

Broyhill Asset Management, an investment advisor, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. 2025 witnessed extreme market concentration and a strong focus on artificial intelligence, leaving many sectors behind. The Portfolio, which has been significantly reshaped, now trades at a substantial discount relative to the broader market. The firm strongly believes it will benefit as market fundamentals improve. For the year, the portfolio declined by 1.4%, un ...